The verdictThe evidence leans bearish for the next 6–12 months. USAR must raise about $675M by 2027-03-31 and a further $875M by 2027-12-31 under its Commerce agreement, with the stock at $11.82. Serra Verde produced only 40 t of rare-earth oxide in 2025, has no named non-China separation route for 2027, and cannot pay USAR dividends until it has repaid DFC debt. The long-term asset case is still real: a government-floored…
Written by Claude (Anthropic’s AI) from public sources · Willem owns USAR · AI can make mistakes — numbers in brackets point to the sources · Not financial advice
Bull arguments show how well they survive the devil’s advocate (strong / medium / weak); bear arguments show the damage they could do after the counter-argument (high / medium / low).
FY2027 consensus: revenue $713.3M, EPS +$0.03 [23]. Because EPS is near zero, "% vs consensus EPS" is meaningless. EPS impacts are given in $/share on ~375M shares, pre-tax (USAR has NOLs; estimate). Consensus share counts are not disclosed.
Heavy-rare-earth upside above the floors reaches the P&L in 2027 — 35% chance in FY2027
A binding multi-year defence or auto magnet contract for Stillwater — 40% chance by end-2027
China re-tightens controls after the truce lapses on 2027-01-10 — 25% chance within 12 months
A price floor or offtake for USAR's own magnets (MP-style) — 15% chance within 36 months
Serra Verde 2027 output or separation falls ≥30% short of plan — 50% chance in FY2027
Equity and converts of ≥$675M by 2027-03-31, at or below today's price — 80% chance by 2027-03-31
Stillwater misses year-end first sales and the 600 t/yr run-rate — 55% chance by Q1 2027
Brazil applies the new law to restrict raw MREC exports or Phase 2 — 15% chance within 36 months
MP wins an injunction on Stillwater's GBD process — 10% chance within 18 months
| # | Factor | Weight | Measured value | Score | Why |
|---|---|---|---|---|---|
| 1 | Liquidity & funding runway | 15% | Pro-forma cash $1.39B; Q2 FCF ≈ −$126M → >10 qtrs at current pace; management plan UFCF Q2–Q4'26 −$804M and 2027 −$2.17B (+$0.49B Serra Verde) → ~12–15 months on plan; $0 Commerce disbursed | 64 | The plan runway is 12–36 months, at the short end. No going-concern language, but contractual raises are due 03-27 and 12-27. |
| 2 | Leverage | 10% | Net cash ≈ $860M pro forma; debt-like ≈ $533M (DFC ~$304M at SOFR+4%, Orion royalty ~$227M); FFB $1.3B to be drawn; negative EBITDA | 35 | Net cash today. Planned borrowing is large while EBITDA is negative, so the score sits above the 0–20 band. |
| 3 | Dilution | 10% | Shares 148.1M (12/31/25) → ~375M (09-26) = +153%; required raises ~$1.55B ≈ +35% at $11.82; DOC warrant 17.6M | 92 | Far above the +25% anchor, with more dilution contractually required. |
| 4 | Profitability | 10% | Q2 revenue $5.8M, gross margin −27.2%, operating loss −$46.3M; Serra Verde H1 revenue $0.59M, operating loss −$39.8M | 88 | Deep losses; the main asset is pre-commercial. |
| 5 | Revenue quality & concentration | 10% | LCM: four customers = 96% of Q2; Serra Verde: one buyer (SPV); no binding magnet contract | 75 | Effectively one asset and one buyer for future revenue. The buyer is US-government backed, which keeps it below 81. |
| 6 | Execution & track record | 10% | First magnet sales slipped Q2 → YE; Commerce docs April → June; PFS folded; LCM 3,000 t softened; 3 CEOs in 13 months; Serra Verde 2 MW-equivalent findings | 78 | Serial slips. No USAR material weakness, so not 81+. |
| 7 | Competitive position & disruption | 10% | MP (DoD floor + offtake, $1.45B cash), eVAC (GM), Vulcan, Lynas ahead in magnets/separation; Serra Verde = rare non-China ionic-clay heavy source | 58 | Contested in magnets, strong in heavy feed. |
| 8 | Cyclicality & commodity/macro sensitivity | 10% | Rare-earth prices; 2023–24 MP revenue −51%, Lynas −37%; ex-China NdPr $95/kg (Aug); Phase-1 floors protect Serra Verde only | 62 | Highly commodity- and policy-linked. Floors cover the contracted mine output, not LCM or magnets. |
| 9 | Regulatory, legal & geopolitical | 5% | China export-control list; Brazil Cimce law (09-16) + STF petition; MP suit; Senate probe; Commerce clawback/debarment | 72 | Large pending exposures with China and Brazil. Not existential on current evidence. |
| 10 | Valuation & expectations | 10% | Market cap ≈ $4.4B, EV ≈ $3.6B ≈ 5x FY27 / 49x FY26 consensus revenue; short 45.2M shares (~12% of shares); average target ~$35 is stale | 70 | Priced for a ramp that has not shown up yet. Heavy shorting and a fragile story. |
Overall: weighted average = 0.15×64 + 0.10×35 + 0.10×92 + 0.10×88 + 0.10×75 + 0.10×78 + 0.10×58 + 0.10×62 + 0.05×72 + 0.10×70 = 9.6 + 3.5 + 9.2 + 8.8 + 7.5 + 7.8 + 5.8 + 6.2 + 3.6 + 7.0 = 69.0 → 69.
Change vs last: +4 (65 under the old 6-area method). What moved:
Ranking check: At 69, USAR ties IREN (69) and sits just above IPX (67). Like IPX it has no profitable product and depends on milestone-paid government money. But its contractual raises, 33.7% resale overhang and unproven mine make it riskier. Its $1.39B of pro-forma cash and floored offtake keep it below WYFI (70), whose own 10-Q warns that resources "may not be sufficient".